We are live on ! Find out more
NRS

Neville Rodie & Shaw Portfolio holdings

AUM $1.55B
1-Year Est. Return 46.95%
This Fund
S&P 500
This Quarter Est. Return
+8.88%
1 Year Est. Return
+46.95%
3 Year Est. Return
+114.59%
5 Year Est. Return
+149.24%
10 Year Est. Return
+498%
AUM
$1.02B
AUM Growth
+$74.7M
Cap. Flow
-$986K
Cap. Flow %
-0.1%
Top 10 Hldgs %
31.61%
Holding
254
New
10
Increased
66
Reduced
77
Closed
4

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$5.43M
2
QCOM icon
Qualcomm
QCOM
+$1.65M
3
BX icon
Blackstone
BX
+$1.52M
4
DIS icon
Walt Disney
DIS
+$869K
5
ZTS icon
Zoetis
ZTS
+$790K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$9.24M
2
BA icon
Boeing
BA
+$1.45M
3
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
+$1.35M
4
XOM icon
ExxonMobil
XOM
+$1.3M
5
AGN
Allergan plc
AGN
+$1.01M

Sector Composition

Rank Sector Weight
1 Healthcare 20.13%
2 Technology 16.35%
3 Financials 15.15%
4 Industrials 12.69%
5 Energy 8.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OUT icon
151
Outfront Media
OUT
$5.5B
$590K 0.06%
22,351
– –
CERN
152
DELISTED
Cerner Corp
CERN
$590K 0.06%
8,040
– –
EOG icon
153
EOG Resources
EOG
$70.7B
$574K 0.06%
6,858
-216
-3% -$15.8K
MDLZ icon
154
Mondelez International
MDLZ
$79.9B
$567K 0.06%
10,286
– –
APD icon
155
Air Products & Chemicals
APD
$67.6B
$543K 0.05%
2,314
-186
-7% -$42K
SU icon
156
Suncor Energy
SU
$70.3B
$542K 0.05%
16,518
-100
-0.6% -$3.12K
HPQ icon
157
HP
HPQ
$27.5B
$536K 0.05%
26,071
– –
RNR icon
158
RenaissanceRe
RNR
$13.4B
$529K 0.05%
2,700
– –
RDS.A
159
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$524K 0.05%
8,881
– –
DTE icon
160
DTE Energy
DTE
$29.1B
$511K 0.05%
4,620
-69
-1% -$7.44K
IP icon
161
International Paper
IP
$22B
$502K 0.05%
11,505
-15,576
-58% -$654K
UTG icon
162
Reaves Utility Income Fund
UTG
$3.61B
$497K 0.05%
13,418
– –
SNA icon
163
Snap-on
SNA
$21.5B
$483K 0.05%
2,850
– –
WEC icon
164
WEC Energy
WEC
$35.1B
$478K 0.05%
5,185
-100
-2% -$9.12K
ET icon
165
Energy Transfer Partners
ET
$69.3B
$472K 0.05%
36,752
-1,217
-3% -$15K
CTVA icon
166
Corteva
CTVA
$51.3B
$468K 0.05%
15,810
-9,818
-38% -$260K
ECL icon
167
Ecolab
ECL
$79.9B
$468K 0.05%
2,425
– –
ADI icon
168
Analog Devices
ADI
$190B
$462K 0.05%
3,889
– –
IAT icon
169
iShares US Regional Banks ETF
IAT
$681M
$432K 0.04%
8,475
-9,050
-52% -$441K
PPL
170
PPL Corp
PPL
$26.7B
$423K 0.04%
11,800
-207
-2% -$6.94K
KEYS icon
171
Keysight
KEYS
$58.3B
$417K 0.04%
4,064
– –
HPE icon
172
Hewlett Packard
HPE
$70.5B
$410K 0.04%
25,871
– –
MRO
173
DELISTED
Marathon Oil Corporation
MRO
$410K 0.04%
30,136
– –
TDG icon
174
TransDigm Group
TDG
$67.7B
$389K 0.04%
695
-50
-7% -$27.4K
WAT icon
175
Waters Corp
WAT
$39.9B
$383K 0.04%
1,637
– –
5 6
7
8 9

Similar funds

BGCP
Bristol Gate Capital Partners Toronto, Ontario, Canada $1.55B AUM 12.75% 1-Year Est. Return
MSA
MUFG Securities Americas New York $1.55B AUM 28.4% 1-Year Est. Return
CET
Clean Energy Transition London, United Kingdom $1.54B AUM 34.41% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
CCM
Cinctive Capital Management New York $1.53B AUM 48.83% 1-Year Est. Return
TNBTD
Trustmark National Bank Trust Department Jackson, Mississippi $1.56B AUM 16.53% 1-Year Est. Return
MCP
Meridiem Capital Partners Dallas, Texas $1.53B AUM 17.03% 1-Year Est. Return
SG
Sienna Gestion Paris, France $1.53B AUM 27.73% 1-Year Est. Return

Neville Rodie & Shaw's Q4 2019 Portfolio in Review

As of Q4 2019, Neville Rodie & Shaw held 254 positions worth $1.02B, up 7.9% from $945M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Neville Rodie & Shaw's Q4 2019 filing shows 10 new, 66 increased, 77 reduced and 4 closed positions. Its largest new stake was Qualcomm: 19,730 shares worth $1.74M. The largest sale was Celgene Corp, an estimated $9.24M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.

  • Neville Rodie & Shaw's largest Q4 2019 buy was Qualcomm: 19,730 shares worth $1.74M.
  • Neville Rodie & Shaw added most to Bristol-Myers Squibb in Q4 2019, an estimated $5.43M increase.
  • Neville Rodie & Shaw's biggest Q4 2019 reduction was Boeing, cutting an estimated $1.45M.
  • Neville Rodie & Shaw fully exited Celgene Corp in Q4 2019, selling an estimated $9.24M.
  • Neville Rodie & Shaw's ten largest holdings make up 32% of its $1.02B portfolio in Q4 2019.
  • Neville Rodie & Shaw opened 10 new positions and closed 4 in Q4 2019.
  • Neville Rodie & Shaw's portfolio value rose 7.9% quarter-over-quarter to $1.02B.

Based on Neville Rodie & Shaw's 13F filing for Q4 2019, filed 8 Jan 2020.